Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Dieldrin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Dieldrin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
gamma-Aminobutyric Acid affects the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|affects reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Lindane inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Lindane inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Picrotoxin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
Picrotoxin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
tert-butylbicyclo-2-benzoate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
tert-butylbicyclo-2-benzoate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C091518 |
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane |
tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C118559 |
1-bromopropane |
1-bromopropane results in increased expression of GABRG2 mRNA | increases expression | 19576243
|
C036531 |
2,6-xylenol |
2,6-xylenol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] | affects binding|increases activity | 11399263
|
C034047 |
2-cresol |
2-cresol results in increased activity of [GABRG2 protein binds to GABRA1 protein binds to GABRB2 protein] | affects binding|increases activity | 11399263
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of GABRG2 mRNA | decreases expression | 18648102
|
C006477 |
alphaxalone |
alphaxalone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
C006477 |
alphaxalone |
alphaxalone results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|increases activity | 12939268
|
D005680 |
gamma-Aminobutyric Acid |
1-Butanol affects the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRG2 protein binds to GABRA1 protein binds to GABRB2 protein]] | affects binding|affects reaction|increases activity | 11137757
|
D005680 |
gamma-Aminobutyric Acid |
beta-thujone inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction|increases activity | 15588619
|
D005680 |
gamma-Aminobutyric Acid |
Camphor promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D005680 |
gamma-Aminobutyric Acid |
carvone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D005680 |
gamma-Aminobutyric Acid |
delta-hexachlorocyclohexane promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein alternative form]] | affects binding|increases activity|increases reaction | 11156579
|
D005680 |
gamma-Aminobutyric Acid |
Diazepam promotes the reaction [gamma-Aminobutyric Acid results in increased activity of GABRG2 protein] | increases activity|increases reaction | 10797553
|
D005680 |
gamma-Aminobutyric Acid |
Etomidate promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]] | affects binding|increases activity|increases reaction | 10049148
|
D005680 |
gamma-Aminobutyric Acid |
Flumazenil promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 8632757
|
D005680 |
gamma-Aminobutyric Acid |
GABRA5 protein affects the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRB2 protein binds to GABRG2 protein]] | affects binding|affects reaction|increases activity | 10987858
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid affects the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|affects reaction | 14637376
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|increases activity | 11812690
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid binds to and results in increased activity of [GABRG2 protein binds to GABRA1 protein binds to GABRB2 protein] | affects binding|increases activity | 11137757
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of GABRG2 protein | increases activity | 10797553
|
D005680 |
gamma-Aminobutyric Acid |
isoborneol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D005680 |
gamma-Aminobutyric Acid |
Lindane inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein alternative form]] | affects binding|decreases reaction|increases activity | 11156579
|
D005680 |
gamma-Aminobutyric Acid |
Menthol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D005680 |
gamma-Aminobutyric Acid |
menthone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D005680 |
gamma-Aminobutyric Acid |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]] | affects binding|increases activity|increases reaction | 10049148
|
D005680 |
gamma-Aminobutyric Acid |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]] | affects binding|increases activity|increases reaction | 10049148
|
D005680 |
gamma-Aminobutyric Acid |
Ro 15-4513 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 8632757
|
D005680 |
gamma-Aminobutyric Acid |
Urethane promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 11812690
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRR1 protein binds to GABRG2 protein] | affects binding|increases activity | 12106692
|
D005680 |
gamma-Aminobutyric Acid |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRR1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12106692
|
D005680 |
gamma-Aminobutyric Acid |
Diazepam promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 1712603
|
D005680 |
gamma-Aminobutyric Acid |
Ethanol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 1712603
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein] | affects binding|increases activity | 1712603
|
D005680 |
gamma-Aminobutyric Acid |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 1712603
|
D005680 |
gamma-Aminobutyric Acid |
alphaxalone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D005680 |
gamma-Aminobutyric Acid |
Etomidate promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects activity|affects binding | 17054655
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|increases activity | 12939268
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABRB2 protein co-treated with GABRG2 protein] | affects cotreatment|increases activity | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
[gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein] | affects cotreatment|increases activity | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA4 protein co-treated with GABRB2 protein co-treated with GABRG2 protein] | affects cotreatment|increases activity | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
[gamma-Aminobutyric Acid results in increased activity of [GABRA4 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein co-treated with GABRB2 protein co-treated with GABRG2 protein] | affects cotreatment|increases activity | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
[gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] | affects binding|increases activity | 11399263
|
D005680 |
gamma-Aminobutyric Acid |
gamma-Aminobutyric Acid results in increased activity of [GABRG2 protein binds to GABRA1 protein binds to GABRB1 protein] | affects binding|increases activity | 2165521
|
D005680 |
gamma-Aminobutyric Acid |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D005680 |
gamma-Aminobutyric Acid |
Picrotoxin inhibits the reaction [gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects activity|affects binding|decreases reaction | 17054655
|
D005680 |
gamma-Aminobutyric Acid |
pregnenolone sulfate inhibits the reaction [gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects activity|affects binding|decreases reaction | 17054655
|
D005680 |
gamma-Aminobutyric Acid |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D005680 |
gamma-Aminobutyric Acid |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
topiramate promotes the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|increases activity|increases reaction|increases transport | 11123204
|
D005680 |
gamma-Aminobutyric Acid |
Zinc inhibits the reaction [gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects activity|affects binding|decreases reaction | 17054655
|
D001569 |
Benzodiazepines |
GABRG2 protein affects the susceptibility to Benzodiazepines | affects response to substance | 7644489
|
C036150 |
beta-carboline-3-carboxylic acid methyl ester |
GABRG2 protein mutant form binds to beta-carboline-3-carboxylic acid methyl ester | affects binding | 10880692
|
C005790 |
beta-thujone |
beta-thujone inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction|increases activity | 15588619
|
D001761 |
Bleomycin |
Bleomycin results in decreased expression of GABRG2 mRNA | decreases expression | 15808516
|
C054626 |
bretazenil |
bretazenil binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
C054626 |
bretazenil |
bretazenil binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
C015044 |
bromoform |
bromoform binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects activity|affects binding | 12505655
|
D020001 |
1-Butanol |
1-Butanol affects the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRG2 protein binds to GABRA1 protein binds to GABRB2 protein]] | affects binding|affects reaction|increases activity | 11137757
|
D002164 |
Camphor |
Camphor promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
C006923 |
carvone |
carvone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D002712 |
Chlorides |
[gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
[gamma-Aminobutyric Acid results in increased activity of [GABRA4 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
[gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides | affects cotreatment|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
D002712 |
Chlorides |
topiramate promotes the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|increases activity|increases reaction|increases transport | 11123204
|
C021604 |
CL 218872 |
CL 218872 binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
C086916 |
delta-hexachlorocyclohexane |
delta-hexachlorocyclohexane promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein alternative form]] | affects binding|increases activity|increases reaction | 11156579
|
C086916 |
delta-hexachlorocyclohexane |
delta-hexachlorocyclohexane results in decreased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein alternative form] | affects binding|decreases activity | 11156579
|
C086916 |
delta-hexachlorocyclohexane |
delta-hexachlorocyclohexane results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein alternative form] | affects binding|decreases activity | 11156579
|
C086916 |
delta-hexachlorocyclohexane |
delta-hexachlorocyclohexane results in decreased activity of [GABRA4 protein binds to GABRB2 protein binds to GABRG2 protein alternative form] | affects binding|decreases activity | 11156579
|
D003975 |
Diazepam |
Diazepam promotes the reaction [gamma-Aminobutyric Acid results in increased activity of GABRG2 protein] | increases activity|increases reaction | 10797553
|
D003975 |
Diazepam |
GABRG2 protein affects the susceptibility to Diazepam | affects response to substance | 10797553
|
D003975 |
Diazepam |
Diazepam promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 1712603
|
D003975 |
Diazepam |
GABRG2 protein mutant form binds to Diazepam | affects binding | 10880692
|
D003975 |
Diazepam |
Diazepam results in increased activity of GABRG2 protein | increases activity | 15613639
|
D003975 |
Diazepam |
GABRG2 protein affects the susceptibility to Diazepam | affects response to substance | 7748319
|
D004026 |
Dieldrin |
Dieldrin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D004026 |
Dieldrin |
Dieldrin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D004026 |
Dieldrin |
Dieldrin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D004026 |
Dieldrin |
Dieldrin results in decreased expression of GABRG2 mRNA | decreases expression | 9302086
|
D007980 |
Levodopa |
Levodopa results in decreased expression of GABRG2 mRNA | decreases expression | 15837143
|
D000431 |
Ethanol |
Ethanol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 1712603
|
D000431 |
Ethanol |
GABRG2 protein affects the susceptibility to Ethanol | affects response to substance | 7748319
|
C044610 |
etizolam |
etizolam results in decreased expression of GABRG2 mRNA alternative form | decreases expression | 16107249
|
D005045 |
Etomidate |
Etomidate promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]] | affects binding|increases activity|increases reaction | 10049148
|
D005045 |
Etomidate |
Etomidate promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D005045 |
Etomidate |
Etomidate results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|increases activity | 12939268
|
D005442 |
Flumazenil |
Flumazenil binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
D005442 |
Flumazenil |
Flumazenil binds to [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding | 8632757
|
D005442 |
Flumazenil |
Flumazenil promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 8632757
|
D005445 |
Flunitrazepam |
Flunitrazepam binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
D005481 |
Flurothyl |
Flurothyl results in decreased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein] | affects binding|decreases activity | 11090101
|
D018682 |
GABA Agents |
GABA Agents binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
D018682 |
GABA Agents |
GABA Agents binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
D006591 |
Hexobarbital |
Hexobarbital affects the expression of GABRG2 mRNA | affects expression | 9336343
|
C022871 |
isoborneol |
isoborneol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
C063822 |
L 663581 |
L 663581 binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
C063822 |
L 663581 |
L 663581 binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
D001556 |
Lindane |
Lindane inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D001556 |
Lindane |
Lindane inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D001556 |
Lindane |
Lindane inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein alternative form]] | affects binding|decreases reaction|increases activity | 11156579
|
D008140 |
Lorazepam |
Lorazepam results in decreased expression of GABRG2 mRNA alternative form | decreases expression | 16107249
|
D008345 |
Manganese |
Manganese results in increased expression of GABRG2 mRNA | increases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in increased expression of GABRG2 mRNA | increases expression | 17175027
|
D008610 |
Menthol |
Menthol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
C019466 |
menthone |
menthone promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 15588619
|
D008874 |
Midazolam |
GABRG2 protein alternative form affects the susceptibility to Midazolam | affects response to substance | 10880692
|
D008874 |
Midazolam |
GABRG2 protein mutant form binds to Midazolam | affects binding | 10880692
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of GABRG2 mRNA | increases expression | 15674844
|
D010424 |
Pentobarbital |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]] | affects binding|increases activity|increases reaction | 10049148
|
D010424 |
Pentobarbital |
Pentobarbital results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2] | affects binding|increases activity | 10049148
|
D010424 |
Pentobarbital |
GABRG2 protein affects the susceptibility to Pentobarbital | affects response to substance | 12106692
|
D010424 |
Pentobarbital |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRR1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12106692
|
D010424 |
Pentobarbital |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB1 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 1712603
|
D010424 |
Pentobarbital |
Pentobarbital affects the expression of GABRG2 mRNA | affects expression | 8787126 9336343
|
D010424 |
Pentobarbital |
Pentobarbital promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D010424 |
Pentobarbital |
Pentobarbital results in decreased expression of GABRG2 mRNA | decreases expression | 8412506
|
D010424 |
Pentobarbital |
Pentobarbital results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|increases activity | 12939268
|
D010424 |
Pentobarbital |
Pentobarbital results in increased activity of [GABRG2 protein binds to GABRA1 protein binds to GABRB1 protein] | affects binding|increases activity | 2165521
|
D010433 |
Pentylenetetrazole |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010433 |
Pentylenetetrazole |
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010433 |
Pentylenetetrazole |
Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010852 |
Picrotoxin |
Picrotoxin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010852 |
Picrotoxin |
Picrotoxin inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010852 |
Picrotoxin |
Picrotoxin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D010852 |
Picrotoxin |
Picrotoxin results in decreased activity of [GABRR1 protein binds to GABRG2 protein] | affects binding|decreases activity | 12106692
|
D010852 |
Picrotoxin |
Picrotoxin inhibits the reaction [gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects activity|affects binding|decreases reaction | 17054655
|
D010852 |
Picrotoxin |
Picrotoxin results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|decreases activity | 17054655
|
C018370 |
pregnenolone sulfate |
pregnenolone sulfate inhibits the reaction [gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects activity|affects binding|decreases reaction | 17054655
|
C018370 |
pregnenolone sulfate |
pregnenolone sulfate results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|decreases activity | 17054655
|
D015742 |
Propofol |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 binds to GABRB1 binds to GABRG2]] | affects binding|increases activity|increases reaction | 10049148
|
D015742 |
Propofol |
Propofol promotes the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 12939268
|
D015742 |
Propofol |
Propofol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|increases activity | 12939268
|
D015742 |
Propofol |
Propofol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] | affects binding|increases activity | 11399263
|
C042957 |
Ro 15-4513 |
Ro 15-4513 binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
C042957 |
Ro 15-4513 |
Ro 15-4513 promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA6 protein binds to GABRB3 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 8632757
|
C042957 |
Ro 15-4513 |
GABRG2 protein mutant form binds to Ro 15-4513 | affects binding | 10880692
|
C009250 |
sevoflurane |
sevoflurane affects the expression of GABRG2 mRNA | affects expression | 15967596
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of GABRG2 mRNA | increases expression | 17879257
|
C046308 |
tert-butylbicyclo-2-benzoate |
tert-butylbicyclo-2-benzoate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C046308 |
tert-butylbicyclo-2-benzoate |
tert-butylbicyclo-2-benzoate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
Dieldrin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
Picrotoxin inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
C037476 |
tert-butylbicyclophosphorothionate |
tert-butylbicyclophosphorothionate inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|decreases reaction | 14637376
|
D043343 |
Testosterone Propionate |
Testosterone Propionate results in decreased expression of GABRG2 mRNA | decreases expression | 16957604
|
D013943 |
Thymol |
Thymol results in increased activity of [GABRG2 binds to GABRA1 binds to GABRB2] | affects binding|increases activity | 11399263
|
D014050 |
Toluene |
Toluene affects the expression of GABRG2 mRNA alternative form | affects expression | 17108153
|
C052342 |
topiramate |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
C052342 |
topiramate |
topiramate inhibits the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA2 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|decreases reaction|increases activity|increases transport | 11123204
|
C052342 |
topiramate |
topiramate promotes the reaction [[gamma-Aminobutyric Acid results in increased activity of [GABRA6 protein co-treated with GABRB2 protein co-treated with GABRG2 protein]] which results in increased transport of Chlorides] | affects cotreatment|increases activity|increases reaction|increases transport | 11123204
|
D014520 |
Urethane |
Urethane promotes the reaction [gamma-Aminobutyric Acid binds to and results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects binding|increases activity|increases reaction | 11812690
|
D015032 |
Zinc |
Zinc results in decreased activity of [GABRR1 protein binds to GABRG2 protein] | affects binding|decreases activity | 12106692
|
D015032 |
Zinc |
GABRG2 protein affects the susceptibility to Zinc | affects response to substance | 10797553
|
D015032 |
Zinc |
Zinc inhibits the reaction [gamma-Aminobutyric Acid binds to and affects the activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] | affects activity|affects binding|decreases reaction | 17054655
|
D015032 |
Zinc |
Zinc results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] | affects binding|decreases activity | 17054655
|
C049109 |
zolpidem |
zolpidem binds to and results in increased activity of [GABRA1 protein binds to GABRB3 protein binds to GABRG2 protein] | affects binding|increases activity | 8632757
|
C049109 |
zolpidem |
GABRG2 protein alternative form affects the susceptibility to zolpidem | affects response to substance | 10880692
|
C049109 |
zolpidem |
GABRG2 protein mutant form binds to zolpidem | affects binding | 10880692
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
3.34 | 18926900 17676605 |
MESH:D000138 |
Acidosis |
|
Ethanol |
3.91 | 11192467 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.81 | 16889938 17202136 17190629 |
MESH:D055371 |
Acute Lung Injury |
|
Bleomycin |
4.34 | 17118201 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
3.16 | 18316556 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
5.11 | 15814487 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
5.85 | 3712494 |
MESH:D000236 |
Adenoma |
|
Urethane |
5.85 | 16926031 11497255 6695378 10530776 10822126 17093202 17195641 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.10 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.30 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
3.79 | 12661182 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.71 | 15451040 15451039 |
MESH:D000437 |
Alcoholism |
|
topiramate |
4.56 | 17925516 18552399 19331489 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.61 | 16325427 16410023 17119284 16580781 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.34 | 16916123 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
9.26 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
9.26 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.24 | 15513904 |
MESH:D000860 |
Anoxia |
|
Bleomycin |
4.82 | 15782499 |
MESH:D001008 |
Anxiety Disorders |
|
Diazepam |
12.47 | 18313124 16284244 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
12.47 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
Pentobarbital |
12.47 | 18313124 11141031 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.47 | 10378619 |
MESH:D001249 |
Asthma |
|
Zinc |
4.47 | 17085522 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
5.03 | 7820390 |
MESH:D001321 |
Autistic Disorder |
|
Benzodiazepines |
4.77 | 17630868 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.41 | 1440618 11289319 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.57 | 19167455 |
MESH:D001836 |
Body Weight Changes |
|
2-cresol |
6.11 | 12820538 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.11 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Dieldrin |
3.09 | 11859874 15770527 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
3.09 | 14688026 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.57 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.37 | 17687719 10378619 |
MESH:D002056 |
Burns |
|
Ethanol |
4.07 | 16374292 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
3.97 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
3.97 | 18788625 15763234 15289165 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.97 | 17306315 16507464 15276417 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.37 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Bleomycin |
6.55 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
6.55 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
6.55 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
3.09 | 19332462 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.24 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
9.10 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
bromoform |
9.10 | 18075178 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.10 | 19524636 20056578 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.26 | 9294310 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
topiramate |
3.85 | 15650499 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
2.70 | 19486331 9022650 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.25 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Diazepam |
8.63 | 3629520 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
8.63 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
8.63 | 12810352 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.63 | 15451040 19302082 10194807 15513904 11198716 11873399 15451039 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
3.63 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
3.63 | 19302082 |
MESH:D003643 |
Death |
|
Pentylenetetrazole |
11.88 | 6431079 |
MESH:D003643 |
Death |
|
Toluene |
11.88 | 6431079 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.26 | 8970840 18759878 2524372 12868966 11906362 8156756 14531868 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.95 | 3621924 2952479 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
3.70 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
topiramate |
3.53 | 16979414 |
OMIM:607208 |
DRAVET SYNDROME |
marker/mechanism |
|
| |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
3.41 | 9022650 18692083 9653073 18289764 8291058 7440962 1440618 18648102 9328219 11289319 6482804 6679447 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
3.41 | 11566570 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
Levodopa |
5.76 | 15893579 3690436 |
MESH:D004421 |
Dystonia |
|
Diazepam |
5.12 | 1851702 |
MESH:D004487 |
Edema |
|
Bleomycin |
5.81 | 17118201 |
MESH:D004487 |
Edema |
|
Mustard Gas |
5.81 | 11402378 11428647 11428631 9260866 |
MESH:D004828 |
Epilepsies, Partial |
|
Diazepam |
4.94 | 3922381 |
MESH:D004827 |
Epilepsy |
|
Diazepam |
6.67 | 821787 |
MESH:D004827 |
Epilepsy |
|
topiramate |
6.67 | 19148780 |
MESH:D004832 |
Epilepsy, Absence |
|
Diazepam |
8.56 | 6426943 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Pentylenetetrazole |
8.56 | 6426943 |
OMIM:607681 |
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2 |
marker/mechanism |
|
| |
MESH:D004833 |
Epilepsy, Temporal Lobe |
|
topiramate |
5.67 | 16499746 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.57 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.25 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
6.25 | 16704527 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
6.25 | 16543248 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
3.22 | 18620774 19236843 16409862 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.06 | 17920746 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.71 | 15513904 10194807 16946407 15451040 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.41 | 6705139 |
MESH:D005756 |
Gastritis |
|
Ethanol |
9.54 | 15046732 |
MESH:D005756 |
Gastritis |
|
Zinc |
9.54 | 17241300 |
OMIM:604233 |
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 |
marker/mechanism |
|
| |
OMIM:611277 |
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3 |
marker/mechanism |
|
| |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.09 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
3.52 | 17043766 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.49 | 7505956 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.56 | 17217573 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
3.82 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.23 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.16 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
3.99 | 17241300 |
MESH:D006501 |
Hepatic Encephalopathy |
marker/mechanism |
|
| 15929193 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
2.96 | 6705139 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.11 | 17276780 |
MESH:D006689 |
Hodgkin Disease |
|
Bleomycin |
6.19 | 15147373 17606976 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.19 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.25 | 18783367 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Levodopa |
5.19 | 16787708 16275827 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.36 | 15034207 |
MESH:D007247 |
Infertility, Female |
|
Dieldrin |
4.39 | 10630421 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.59 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Bleomycin |
4.63 | 17118201 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
4.63 | 8975870 16001271 9260866 11402378 17524151 11428631 11428647 11428620 9357497 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.05 | 16584753 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.41 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
3.87 | 15513904 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.16 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
5.16 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
3.89 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.49 | 6582329 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
8.14 | 15451040 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
8.14 | 19212262 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.38 | 17676605 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.02 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.50 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.80 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
2.30 | 18166357 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
2.94 | 1715830 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.07 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
Dieldrin |
6.26 | 9539021 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
6.26 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
6.26 | 17559639 17093202 16391232 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.16 | 3712494 1399818 598648 6587162 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
6.16 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.16 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Bleomycin |
4.23 | 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
4.23 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.23 | 19931552 16712894 15276417 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
4.23 | 7750092 11323394 17093202 11992545 11062179 11893704 16788158 16289808 11246140 17255336 12117781 10822126 11074608 16926031 16007126 10997738 16391232 15166089 11307925 12765245 10530776 12957351 15136453 6695378 10779650 11807781 11552296 16204055 14587096 11497255 17195641 16337739 15902970 12466968 11544531 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
2.92 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
4.92 | 16551646 16568477 19453300 |
MESH:D008545 |
Melanoma |
|
Bleomycin |
3.40 | 15577320 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.40 | 16487513 19082730 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
8.11 | 18411066 15451040 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
8.11 | 19212262 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
3.42 | 9294310 |
MESH:D008881 |
Migraine Disorders |
|
topiramate |
4.15 | 18759728 18765137 16942474 18803445 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.69 | 9294310 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.46 | 16551646 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.20 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Dieldrin |
9.34 | 8820588 |
MESH:D009369 |
Neoplasms |
|
Lindane |
9.34 | 16818664 12807735 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
9.34 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Urethane |
9.34 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.57 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
7.57 | 15582191 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
3.81 | 16551646 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
5.91 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
5.91 | 12854658 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.43 | 16761898 7688884 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
2.91 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.41 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.54 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
4.54 | 16391232 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
2.73 | 12384795 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
2.91 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Dieldrin |
7.63 | 16112328 17291500 11445065 16809432 11181820 |
MESH:D010300 |
Parkinson Disease |
|
Levodopa |
7.63 | 19594199 20334432 7566641 18328768 11432539 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
7.63 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Levodopa |
8.37 | 8817341 11246459 18722529 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
8.37 | 16140633 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.87 | 6228378 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
4.83 | 16391232 |
MESH:D011014 |
Pneumonia |
|
Bleomycin |
4.82 | 16317386 17071938 18024389 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.26 | 15727166 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.71 | 17114810 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
3.04 | 14688026 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.04 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.04 | 16606632 16517595 16700911 12429649 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.51 | 18058305 |
MESH:D011595 |
Psychomotor Agitation |
|
Benzodiazepines |
6.32 | 20581379 |
MESH:D011654 |
Pulmonary Edema |
|
Bleomycin |
4.72 | 15808516 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Bleomycin |
5.33 | 18162602 16115399 17177178 16314464 21435439 14609568 17434272 11554783 15322207 17241526 12624602 15541506 18008008 12574379 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.33 | 17894541 17620002 17266442 10334151 17720292 |
MESH:D012004 |
Rectal Neoplasms |
|
bromoform |
5.78 | 17535441 |
MESH:D012021 |
Reflex, Abnormal |
|
Pentobarbital |
5.43 | 10930210 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
7.50 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
7.50 | 16584753 |
MESH:C537537 |
Segawa syndrome, autosomal recessive |
|
Levodopa |
6.10 | 8817341 |
MESH:D012640 |
Seizures |
|
Diazepam |
48.02 | 9754883 15946322 10087439 |
MESH:D012640 |
Seizures |
|
Ethanol |
48.02 | 9754883 |
MESH:D012640 |
Seizures |
|
etizolam |
48.02 | 16107249 |
MESH:D012640 |
Seizures |
|
Flurothyl |
48.02 | 3352866 |
MESH:D012640 |
Seizures |
|
Lindane |
48.02 | 15475178 12842176 7539098 |
MESH:D012640 |
Seizures |
|
Lorazepam |
48.02 | 16107249 10087439 |
MESH:D012640 |
Seizures |
|
Midazolam |
48.02 | 10087439 |
MESH:D012640 |
Seizures |
|
Pentobarbital |
48.02 | 10087439 9754883 |
MESH:D012640 |
Seizures |
|
Pentylenetetrazole |
48.02 | 18164287 19660546 8954991 2616065 18657176 3352866 3037702 15475178 16054440 6431079 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
48.02 | 8635557 8954991 |
MESH:D012640 |
Seizures |
|
Toluene |
48.02 | 9294310 6431079 |
MESH:D012640 |
Seizures |
|
topiramate |
48.02 | 16499746 |
MESH:D012640 |
Seizures |
|
zolpidem |
48.02 | 9754883 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.54 | 12880345 16961503 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.17 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
5.17 | 11807781 |
MESH:D012893 |
Sleep Disorders |
|
Midazolam |
10.09 | 6138072 |
MESH:D012893 |
Sleep Disorders |
|
zolpidem |
10.09 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Lorazepam |
13.85 | 15341891 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Midazolam |
13.85 | 6138071 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
zolpidem |
13.85 | 15341891 9066939 17225163 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.33 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.30 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.03 | 9211565 11906479 9562338 17918041 17189318 16755016 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Diazepam |
19.28 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
19.28 | 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Pentobarbital |
19.28 | 11529278 9754883 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
zolpidem |
19.28 | 9754883 |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.37 | 10514026 10048760 |
MESH:D013742 |
Tetanus |
|
Midazolam |
12.12 | 2903605 |
MESH:D013742 |
Tetanus |
|
Propofol |
12.12 | 2903605 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.44 | 6587162 6582329 7505956 1399818 3712494 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
3.88 | 16543248 |
MESH:D014202 |
Tremor |
|
2-cresol |
5.77 | 12820538 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.20 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.20 | 11723127 17306315 16452187 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.25 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.83 | 17056641 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.31 | 10620525 |
MESH:D015431 |
Weight Loss |
|
Bleomycin |
5.05 | 12624602 |